LITTLE ROCK, Ark. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces the enrollment of the first U.S. patient in the CONNECT II global clinical trial. Dr. Ian Cawich of Arkansas Heart Hospital enrolled the first U.S. patient this morning. This announcement comes just two weeks after Dr. Bernhard Reimers enrolled the first European patient in the CONNECT II trial at Ospedale di Mirano in Mirano, Italy.
